-
ICPerMed Action Plan for Personalised Medicine published
22 March 2017 – The International Consortium for Personalised Medicine (ICPerMed) identifies future research needs in a common Action Plan. The aim of ICPerMed is to boost personalised medicine by an enhanced coordination and alignment of research activities. Over the past year, the members of ICPerMed have developed a common Action Plan with central research…
-
ICPerMed@EMA
On March 14th, Judit Molnar, member of ICPerMed’s Steering Board, represented ICPerMed at the workshop of the European Medicines Agency (EMA) about “Personalised medicines – focus on patients and healthcare professionals” in London.
-
ICPerMed@(Bio)Pharma Ireland Seminar
On February 28th, Charlotte Videbaek, member of ICPerMed’s Steering Board, represented ICPerMed at the (Bio)Pharma Ireland high-level seminar: “The future of (bio)pharmaceutical manufacturing” that took place in Brussels.
-
Official Launch of ICPerMed
Brussels, 24 November 2016 – Personalised medicine is a promising new concept for dealing with challenges of health and health systems. With the launch of the International Consortium for Personalised Medicine (ICPerMed), European countries aim to coordinate health research policy to advance the implementation of personalised medicine.
-
ICPerMed Article in Clinical and Translational Science
28 February 2017 – Elmar Nimmesgern, Indridi Benediktsson and Irene Norstedt from the European Commission recently published an article about ICPerMed: „Personalised Medicine in Europe“. It gives a very good overview about the background of ICPerMed and about current developments in personalised medicine in general and underlines that “[…] the time is ripe for a…
